This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In 2009, former Biogen employee Michael Bawduniak filed a lawsuit claiming that Biogen had violated the False Claims Act and the Anti-Kickback Statute by providing millions of dollars to healthcareproviders (HCPs) as an incentive to prescribe three of its multiple sclerosis (MS) drugs.
Since the inception of electronic health records (EHR) in 2009, the American medical practice has been transitioning to the cloud. One of the latest iterations of our digitization comes in the form of the patient portal, an online hub designed to keep healthcare consumers in the treatment loop. For Providers. Better bottom line.
Most healthcareproviders’ priorities include retaining patients and improving referral patterns to increase revenue. It also shows that doctors are unlikely to change their referral patterns unless they are actively engaged by a physician liaison team member.
During the 2009–19 period, children in the US ages five years and younger accounted for 58, 000 annual RSV-related hospitalisations and 100–500 annual deaths. This would be preferable for patients as doctors must administer Synagis to patients five times per month during peak RSV season.
District Judge Kimba Wood dismissed a whistleblower lawsuit against Novartis, that claimed the company had bribed doctors with kickbacks at speaker programs to incentivise doctors to prescribe Gilenya. This is the second time that allegations of Novartis violating the False Claims Act have been dismissed in the last three years.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content